Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)

Small Molecules Studied

HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10273-1 Purvalanol A LSM-3118 456214
10514-1 PS-1145 9949093
10265-1 Pevonedistat
MLN 4924; MLN-4924; MLN4924
LSM-6263 16720766
10272-1 Pemetrexed
Alimta
LSM-6353 446556
10271-2 PD 98059 LSM-3394 4713
10048 PD184352
CI-1040
LSM-1048 6918454
10048-6 PD184352
CI-1040
LSM-1048 6918454
10048-7 PD184352
CI-1040
LSM-1048 6918454
10026-3 PD173074 LSM-1026 1401
10270-1 Oxamflatin LSM-4290 4611
10269-1 Oxaliplatin
Eloxatin
LSM-44941 5310940
10146-2 Omipalisib
GSK2126458; GSK2126458A
LSM-1147 25167777
10344-1 Olomoucine II LSM-6356 10067756
10268-1 Nutlin 3a LSM-6351 11433190
10267-1 NU6102 LSM-4287 4566
10266-1 NSC 663284 LSM-2042 379077
10099-2 Nilotinib
AMN-107
LSM-1099 644241
10513-1 Nelfinavir
Viracept
64143
10107-2 MG-132 LSM-1107 462382
10107 MG-132 LSM-1107 462382
10107-5 MG-132 LSM-1107 462382
10264-1 Methotrexate
Rheumatrex; Trexall; Amethopterin; MTX
LSM-5690 126941
10511-1 Mebendazole
Vermox
4030
10230-2 Lestaurtinib
CEP-701
LSM-1231 126565
10263-1 LBH589
Panobinostat
LSM-4284 57519507